Aarti Drugs Ltd - 524348 - Draft Letter of Offer
Inga Advisors Private Limited ("Manager to the Buyback Offer") has submitted to BSE a copy of Draft Letter of Offer to the Equity Shareholders of Aarti Drugs Ltd ("the Company").28-03-2019
Aarti Drugs Ltd - 524348 - Draft Letter of Offer
Inga Advisors Private Limited ("Manager to the Buyback Offer") has submitted to BSE a copy of Draft Letter of Offer to the Equity Shareholders of Aarti Drugs Ltd ("the Company").AARTI DRUGS LTD. - 524348 - Announcement Under Regulation 30 SEBI(LODR)- Update
Intimation of change in Compliance Officer.AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Key Managerial Personnel under Regulation 30 read with Part A, Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates / Issue of Duplicate Share Certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015Aarti Drugs Ltd - 524348 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Aarti Drugs Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereAARTI DRUGS LTD. - 524348 - Submission Of Outcome Of Voting Results Of Postal Ballot.
Submission of Outcome of Voting Results of Postal Ballot under Regulation 44 of SEBI (LODR) Regulations, 2015Aarti Drugs Ltd - 524348 - Buyback Offer
Inga Advisors Private Limited ("Manager to the Buyback Offer") has submitted to BSE a copy of Public Announcement for the attention of Equity Shareholders / Beneficial Owners of Equity Shares of Aarti Drugs Ltd ("Target Company") for the Buyback of Equity Shares through a Tender Offer under Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018, as amended ("Buyback Regulations").AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates / Issue of Duplicate Share Certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015AARTI DRUGS LTD. - 524348 - Updates On Buyback
Submission of Certified True Copy of Board Resolution approving Buyback under Regulation 5(vii) of SEBI (Buyback of Securities) Regulations, 2018.AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares
Public Announcement for Buyback of Equity shares of Aarti Drugs Limited.